Furthermore, we treated SCC1 cells with another BET inhibitor I-BET-1516, and confirmed that BET inhibition suppressed the expression of NF-κB target genes and cancer stemness genes (Supplementary Fig. 1c). The gene discussed is NFKB1; the disease is cancer.